{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:13:53Z","timestamp":1786986833501,"version":"build-2736575974"},"reference-count":182,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.clinbiochem.2025.110912","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T20:15:19Z","timestamp":1741724119000},"page":"110912","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Rising illicit drug Adulterants: Xylazine and levamisole"],"prefix":"10.1016","volume":"137","author":[{"given":"Pedro E.M.","family":"Amaral","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel O.","family":"Beane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angie","family":"Albarouki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan J.","family":"Schoenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sacha N.","family":"Uljon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusheng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Donald C","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4664-2615","authenticated-orcid":false,"given":"Yinghua","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2025.110912_b0005","unstructured":"Title 21 of the United States Code (USC) Controlled Substances Act. United States Drug Enforcement Administration."},{"key":"10.1016\/j.clinbiochem.2025.110912_b0010","unstructured":"The Growing Threat of Xylazine and its Mixture with Illicit Drugs. 2022, Drug Enforcement Administration (DEA)."},{"key":"10.1016\/j.clinbiochem.2025.110912_b0015","unstructured":"Weixel, N. White House says fentanyl laced with \u2018tranq\u2019 drug is \u2019emerging threat\u2019. April 12st 2023 [cited 2024 February 13th]; Available from: https:\/\/thehill.com\/policy\/healthcare\/3945198-white-house-says-fentanyl-laced-with-tranq-drug-is-emerging-threat\/."},{"key":"10.1016\/j.clinbiochem.2025.110912_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jflm.2023.102542","article-title":"The first drug-related death associated with xylazine use in the UK and Europe","volume":"97","author":"Rock","year":"2023","journal-title":"J. Forensic Leg. Med."},{"key":"10.1016\/j.clinbiochem.2025.110912_b0025","unstructured":"Agranulocytosis associated with cocaine use - four States, March 2008-November 2009. MMWR Morb Mortal Wkly Rep, 2009. 58(49): p. 1381-5."},{"key":"10.1016\/j.clinbiochem.2025.110912_b0030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232314619","article-title":"Molecular insights and clinical outcomes of drugs of abuse adulteration: new trends and new psychoactive substances","volume":"23","author":"Di Trana","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.clinbiochem.2025.110912_b0035","doi-asserted-by":"crossref","first-page":"287","DOI":"10.7326\/0003-4819-150-4-200902170-00102","article-title":"Agranulocytosis after consumption of cocaine adulterated with levamisole","volume":"150","author":"Zhu","year":"2009","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.clinbiochem.2025.110912_b0040","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.annemergmed.2008.10.017","article-title":"Levamisole found in patients using cocaine","volume":"53","author":"Kinzie","year":"2009","journal-title":"Ann. Emerg. Med."},{"issue":"6","key":"10.1016\/j.clinbiochem.2025.110912_b0045","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1525-1470.1997.tb00695.x","article-title":"Ear lobe bilateral necrosis by levamisole-induced occlusive vasculitis in a pediatric patient","volume":"14","author":"Menni","year":"1997","journal-title":"Pediatr Dermatol"},{"issue":"11","key":"10.1016\/j.clinbiochem.2025.110912_b0050","doi-asserted-by":"crossref","first-page":"758","DOI":"10.7326\/0003-4819-152-11-201006010-00026","article-title":"Bilateral necrosis of earlobes and cheeks: another complication of cocaine contaminated with levamisole","volume":"152","author":"Bradford","year":"2010","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.clinbiochem.2025.110912_b0055","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2885.1988.tb00189.x","article-title":"Xylazine\u2013a review of its pharmacology and use in veterinary medicine","volume":"11","author":"Greene","year":"1988","journal-title":"J Vet Pharmacol Ther"},{"key":"10.1016\/j.clinbiochem.2025.110912_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.forsciint.2014.03.015","article-title":"Xylazine intoxication in humans and its importance as an emerging adulterant in abused drugs: A comprehensive review of the literature","volume":"240","author":"Ruiz-Col\u00f3n","year":"2014","journal-title":"Forensic Sci Int"},{"issue":"6","key":"10.1016\/j.clinbiochem.2025.110912_b0065","article-title":"The new stealth drug on the street: a narrative review of xylazine as a street drug","volume":"15","author":"Pergolizzi","year":"2023","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.clinbiochem.2025.110912_b0070","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s11524-011-9662-6","article-title":"The emerging of xylazine as a new drug of abuse and its health consequences among drug users in Puerto Rico","volume":"89","author":"Reyes","year":"2012","journal-title":"J Urban Health"},{"issue":"16","key":"10.1016\/j.clinbiochem.2025.110912_b0075","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1001\/jama.299.16.1937","article-title":"Efficacy of current drugs against soil-transmitted helminth infections: systematic review and meta-analysis","volume":"299","author":"Keiser","year":"2008","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.clinbiochem.2025.110912_b0080","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/0192-0561(92)90179-O","article-title":"Levamisole, the story and the lessons","volume":"14","author":"Amery","year":"1992","journal-title":"Int J Immunopharmacol"},{"issue":"2","key":"10.1016\/j.clinbiochem.2025.110912_b0085","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/FTD.0000000000000851","article-title":"Levamisole-a toxic adulterant in illicit drug preparations: a review","volume":"43","author":"Midthun","year":"2021","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.clinbiochem.2025.110912_b0090","series-title":"From reliable sources: an introduction to historical methods","first-page":"77","author":"Howell","year":"2001"},{"issue":"2","key":"10.1016\/j.clinbiochem.2025.110912_b0095","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2165\/00128071-200405020-00004","article-title":"Levamisole in dermatology : a review","volume":"5","author":"Scheinfeld","year":"2004","journal-title":"Am J Clin Dermatol"},{"issue":"6","key":"10.1016\/j.clinbiochem.2025.110912_b0100","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.mayocp.2012.03.010","article-title":"Complications associated with use of levamisole-contaminated cocaine: an emerging public health challenge","volume":"87","author":"Lee","year":"2012","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"10.1016\/j.clinbiochem.2025.110912_b0105","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.pathol.2018.03.006","article-title":"The cocaine cutting agent levamisole is frequently detected in cocaine users","volume":"50","author":"Pope","year":"2018","journal-title":"Pathology"},{"key":"10.1016\/j.clinbiochem.2025.110912_b0110","unstructured":"Drugs@FDA: FDA-Approved Drugs. U.S. Food and Drug Administration: FDA."},{"key":"10.1016\/j.clinbiochem.2025.110912_b0115","unstructured":"Xylazine: What Clinicians Need to Know. [cited 2023 31 October]; Available from: https:\/\/www.health.ny.gov\/publications\/12044.pdf."},{"issue":"3","key":"10.1016\/j.clinbiochem.2025.110912_b0120","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.drugalcdep.2008.03.005","article-title":"GC-MS confirmation of xylazine (Rompun), a veterinary sedative, in exchanged needles","volume":"96","author":"Rodr\u00edguez","year":"2008","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.clinbiochem.2025.110912_b0125","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1747-597X-6-7","article-title":"Xylazine (veterinary sedative) use in Puerto Rico","volume":"6","author":"Torruella","year":"2011","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"10.1016\/j.clinbiochem.2025.110912_b0130","unstructured":"Middleton, J. Opioid Epidemic Updates: \u201cFrankenstein Opioids\u201d and Xylazine-Induced Skin Ulcers. February 13th 2023 [cited 2024 February 13th]; Available from: https:\/\/www.aafp.org\/pubs\/afp\/afp-community-blog\/entry\/opioid-epidemic-updates-frankenstein-opioids-and-xylazine-induced-skin-ulcers.html."},{"issue":"10","key":"10.1016\/j.clinbiochem.2025.110912_b0135","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.7326\/M23-2001","article-title":"Xylazine Adulteration of the Heroin-Fentanyl Drug Supply : A Narrative Review","volume":"176","author":"D'Orazio","year":"2023","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinbiochem.2025.110912_b0140","unstructured":"DEA Reports Widespread Threat of Fentanyl Mixed with Xylazine. November 2022 [cited 2024 Februrary 13th]; Available from: https:\/\/www.dea.gov\/alert\/dea-reports-widespread-threat-fentanyl-mixed-xylazine."},{"issue":"4","key":"10.1016\/j.clinbiochem.2025.110912_b0145","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/injuryprev-2020-043968","article-title":"Increasing presence of xylazine in heroin and\/or fentanyl deaths, Philadelphia, Pennsylvania, 2010-2019","volume":"27","author":"Johnson","year":"2021","journal-title":"Inj Prev"},{"key":"10.1016\/j.clinbiochem.2025.110912_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109380","article-title":"Xylazine spreads across the US: A growing component of the increasingly synthetic and polysubstance overdose crisis","volume":"233","author":"Friedman","year":"2022","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.clinbiochem.2025.110912_b0155","article-title":"Perspectives of people in Philadelphia who use fentanyl\/heroin adulterated with the animal tranquilizer xylazine; Making a case for xylazine test strips","volume":"4","author":"Reed","year":"2022","journal-title":"Drug Alcohol Depend Rep"},{"issue":"6","key":"10.1016\/j.clinbiochem.2025.110912_b0160","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/ADM.0000000000001216","article-title":"Self-reported xylazine experiences: a mixed-methods study of Reddit subscribers","volume":"17","author":"Spadaro","year":"2023","journal-title":"J Addict Med"},{"key":"10.1016\/j.clinbiochem.2025.110912_b0165","unstructured":"Health Update: Xylazine (tranq) exposure among people who use substances in Philadelphia. December 8th 2022 [cited 2024 February 13th]; Available from: https:\/\/hip.phila.gov\/document\/3154\/PDPH-HAN_Update_13_Xylazine_12.08.2022.pdf\/."},{"issue":"17","key":"10.1016\/j.clinbiochem.2025.110912_b0170","doi-asserted-by":"crossref","first-page":"458","DOI":"10.15585\/mmwr.mm7217a2","article-title":"Rapid analysis of drugs: a pilot surveillance system to detect changes in the illicit drug supply to guide timely harm reduction responses - eight syringe services programs, Maryland, November 2021-August 2022","volume":"72","author":"Russell","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"10.1016\/j.clinbiochem.2025.110912_b0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0199087","article-title":"Faster emergence behavior from ketamine\/xylazine anesthesia with atipamezole versus yohimbine","volume":"13","author":"Mees","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.clinbiochem.2025.110912_b0180","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1556-4029.2007.00648.x","article-title":"Concurrent detection of heroin, fentanyl, and xylazine in seven drug-related deaths reported from the philadelphia medical examiner\u2019s office","volume":"53","author":"Wong","year":"2008","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.clinbiochem.2025.110912_b0185","series-title":"Unintentional Drug Overdose Fatalities in Philadelphia","author":"Higgins","year":"2021"},{"issue":"8","key":"10.1016\/j.clinbiochem.2025.110912_b0190","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.2105\/AJPH.2022.306881","article-title":"Xylazine and overdoses: trends, concerns, and recommendations","volume":"112","author":"Alexander","year":"2022","journal-title":"Am. J. Public Health"},{"issue":"37","key":"10.1016\/j.clinbiochem.2025.110912_b0195","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.15585\/mmwr.mm7037a4","article-title":"Notes from the field: xylazine detection and involvement in drug overdose deaths - United States, 2019","volume":"70","author":"Kariisa","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.clinbiochem.2025.110912_b0200","unstructured":"FDA alerts health care professionals of risks to patients exposed to xylazine in illicit drugs. November 8th 2022 [cited 2024 February 13th]; Available from: https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-alerts-health-care-professionals-risks-patients-exposed-xylazine-illicit-drugs."},{"key":"10.1016\/j.clinbiochem.2025.110912_b0205","unstructured":"Cocaine Laced With Veterinary Drug Levamisole Eats Away at Flesh. June 22nd 2011 [cited 2024 February 13th]; Available from: https:\/\/abcnews.go.com\/Health\/Wellness\/flesh-eating-cocaine-laced-veterinary-drug-levamisole\/story?id=13902353."},{"key":"10.1016\/j.clinbiochem.2025.110912_b0210","unstructured":"2017 National Drug Threat Assessment. Drug Enforcement Administration: DEA. p. 84."},{"key":"10.1016\/j.clinbiochem.2025.110912_b0215","first-page":"16","article-title":"Identification of levamisole and lidocaine acetylation reaction impurities found in heroin exhibits","volume":"8","author":"Casale","year":"2011","journal-title":"Microgram J."},{"issue":"3","key":"10.1016\/j.clinbiochem.2025.110912_b0220","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/1556-4029.13968","article-title":"Detection of cutting agents in drug-positive seized exhibits within the United States","volume":"64","author":"Fiorentin","year":"2019","journal-title":"J. Forensic Sci."},{"issue":"16","key":"10.1016\/j.clinbiochem.2025.110912_b0225","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1001\/jama.2011.531","article-title":"Prevalence of levamisole in urine toxicology screens positive for cocaine in an inner-city hospital","volume":"305","author":"Buchanan","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.clinbiochem.2025.110912_b0230","unstructured":"Levamisole (Trade Name: Ergamisol\u00ae). 2023; Available from: www.deadiversion.usdoj.gov\/drug_chem_info\/levamisole.pdf."},{"key":"10.1016\/j.clinbiochem.2025.110912_b0235","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.forsciint.2016.01.005","article-title":"Levamisole-adulterated cocaine: Two fatal case reports and evaluation of possible cocaine toxicity potentiation","volume":"265","author":"Indorato","year":"2016","journal-title":"Forensic Sci Int"},{"issue":"1","key":"10.1016\/j.clinbiochem.2025.110912_b0240","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000329436","article-title":"Necrosis of ears after use of cocaine probably adulterated with levamisole","volume":"223","author":"de la Hera","year":"2011","journal-title":"Dermatology"},{"issue":"17","key":"10.1016\/j.clinbiochem.2025.110912_b0245","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/MD.0000000000000090","article-title":"Pauci-immune glomerulonephritis in individuals with disease associated with levamisole-adulterated cocaine: a series of 4 cases","volume":"93","author":"Carlson","year":"2014","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.clinbiochem.2025.110912_b0250","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/clpt.2010.156","article-title":"Levamisole: a dangerous new cocaine adulterant","volume":"88","author":"Chang","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clinbiochem.2025.110912_b0255","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.neuropharm.2014.01.002","article-title":"Levamisole and cocaine synergism: a prevalent adulterant enhances cocaine's action in vivo","volume":"79","author":"Tallarida","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.clinbiochem.2025.110912_b0260","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.forsciint.2015.02.006","article-title":"Drug-related death: adulterants from cocaine preparations in lung tissue and blood","volume":"249","author":"Pawlik","year":"2015","journal-title":"Forensic Sci Int"},{"issue":"6","key":"10.1016\/j.clinbiochem.2025.110912_b0265","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1007\/s00204-017-1947-4","article-title":"Adverse effects of levamisole in cocaine users: a review and risk assessment","volume":"91","author":"Brunt","year":"2017","journal-title":"Arch Toxicol"},{"issue":"100","key":"10.1016\/j.clinbiochem.2025.110912_b0270","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.neuint.2013.11.010","article-title":"Aminorex, a metabolite of the cocaine adulterant levamisole, exerts amphetamine like actions at monoamine transporters","volume":"73","author":"Hofmaier","year":"2014","journal-title":"Neurochem Int"},{"issue":"4","key":"10.1016\/j.clinbiochem.2025.110912_b0275","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/jat\/bky102","article-title":"Plasma and urine levamisole in clinical samples containing benzoylecgonine: absence of aminorex","volume":"43","author":"Handley","year":"2019","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.clinbiochem.2025.110912_b0280","series-title":"Xylazine toxicity","first-page":"26","author":"Regina","year":"2023"},{"issue":"24","key":"10.1016\/j.clinbiochem.2025.110912_b0285","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMp2303120","article-title":"Xylazine - medical and public health imperatives","volume":"388","author":"Gupta","year":"2023","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.clinbiochem.2025.110912_b0290","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/0091-3057(85)90537-4","article-title":"Pharmacology of spinal adrenergic systems which modulate spinal nociceptive processing","volume":"22","author":"Yaksh","year":"1985","journal-title":"Pharmacol Biochem Behav"},{"issue":"5","key":"10.1016\/j.clinbiochem.2025.110912_b0295","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0028-3908(74)90113-0","article-title":"Antagonism of the antinociceptive action of xylazine, an alpha-sympathomimetic agent, by adrenoceptor and cholinoceptor blocking agents","volume":"13","author":"Schmitt","year":"1974","journal-title":"Neuropharmacology"},{"issue":"7","key":"10.1016\/j.clinbiochem.2025.110912_b0300","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.pt.2012.04.003","article-title":"Levamisole receptors: a second awakening","volume":"28","author":"Martin","year":"2012","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.clinbiochem.2025.110912_b0305","unstructured":"Mulayim, M.K., P. Ozturk, and S. Korkmaz, LEVAMISOLE USES IN DERMATOLOGY. Immunomodulatory and Immunsuppressive Drugs in Dermatology: p. 157-164."},{"issue":"1","key":"10.1016\/j.clinbiochem.2025.110912_b0310","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10456-005-3588-0","article-title":"Levamisole inhibits angiogenesis in vitro and tumor growth in vivo","volume":"8","author":"Friis","year":"2005","journal-title":"Angiogenesis"},{"key":"10.1016\/j.clinbiochem.2025.110912_b0315","first-page":"119","article-title":"Augmentation of IL12-dependent Th1 cytokine production by levamisole","volume":"9","author":"Holcombe","year":"1997","journal-title":"Allergy Clin Immunol Int"},{"issue":"1","key":"10.1016\/j.clinbiochem.2025.110912_b0320","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2253-13-33","article-title":"Xylazine-induced reduction of tissue sensitivity to insulin leads to acute hyperglycemia in diabetic and normoglycemic monkeys","volume":"13","author":"Xiao","year":"2013","journal-title":"BMC Anesthesiol"},{"key":"10.1016\/j.clinbiochem.2025.110912_b0325","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/492609","article-title":"Xylazine as a drug of abuse and its effects on the generation of reactive species and DNA damage on human umbilical vein endothelial cells","volume":"2014","author":"Silva-Torres","year":"2014","journal-title":"J Toxicol"},{"issue":"5","key":"10.1016\/j.clinbiochem.2025.110912_b0330","first-page":"567","article-title":"Pharmacokinetics of ketamine and xylazine in young and old Sprague-Dawley rats","volume":"52","author":"Veilleux-Lemieux","year":"2013","journal-title":"J Am Assoc Lab Anim Sci"},{"issue":"30","key":"10.1016\/j.clinbiochem.2025.110912_b0335","doi-asserted-by":"crossref","first-page":"9779","DOI":"10.1007\/s00216-013-7419-7","article-title":"Qualitative metabolism assessment and toxicological detection of xylazine, a veterinary tranquilizer and drug of abuse, in rat and human urine using GC-MS, LC-MSn, and LC-HR-MSn","volume":"405","author":"Meyer","year":"2013","journal-title":"Anal Bioanal Chem"},{"issue":"2","key":"10.1016\/j.clinbiochem.2025.110912_b0340","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2885.1981.tb00715.x","article-title":"The pharmacokinetics of xylazine hydrochloride: an interspecific study","volume":"4","author":"Garcia-Villar","year":"1981","journal-title":"J Vet Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.clinbiochem.2025.110912_b0345","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/bmc.2875","article-title":"Characterization of xylazine metabolism in rat liver microsomes using liquid chromatography-hybrid triple quadrupole-linear ion trap-mass spectrometry","volume":"27","author":"Lavoie","year":"2013","journal-title":"Biomed Chromatogr"},{"issue":"2","key":"10.1016\/j.clinbiochem.2025.110912_b0350","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2165\/00003088-198815020-00001","article-title":"Clinical pharmacokinetics of anthelmintic drugs","volume":"15","author":"Edwards","year":"1988","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinbiochem.2025.110912_b0355","first-page":"137","article-title":"Pharmacokinetics of levamisole","volume":"4","author":"Adams","year":"1978","journal-title":"J Rheumatol Suppl"},{"issue":"1","key":"10.1016\/j.clinbiochem.2025.110912_b0360","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/bdd.2510070110","article-title":"Novel assay and pharmacokinetics of levamisole and p-hydroxylevamisole in human plasma and urine","volume":"7","author":"Kouassi","year":"1986","journal-title":"Biopharm Drug Dispos"},{"issue":"4","key":"10.1016\/j.clinbiochem.2025.110912_b0365","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF03189626","article-title":"Pharmacokinetics of levamisole in healthy subjects and cancer patients","volume":"7","author":"Luyckx","year":"1982","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.clinbiochem.2025.110912_b0370","first-page":"235","article-title":"Pharmacokinetic studies on levamisole: on the pharmacokinetics and relative bioavailability of levamisole in man","volume":"2","author":"Graziani","year":"1977","journal-title":"Drugs Exp. Clin. Res"},{"issue":"1","key":"10.1016\/j.clinbiochem.2025.110912_b0375","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.aca.2006.03.068","article-title":"Pharmacokinetics and brain distribution of unbound levamisole in the anesthetized rats using microdialysis and microbore column liquid chromatography","volume":"569","author":"Lin","year":"2006","journal-title":"Anal. Chim. Acta"},{"issue":"6","key":"10.1016\/j.clinbiochem.2025.110912_b0380","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1124\/dmd.112.045021","article-title":"Immune-mediated agranulocytosis caused by the cocaine adulterant levamisole: a case for reactive metabolite(s) involvement","volume":"40","author":"Wolford","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.clinbiochem.2025.110912_b0385","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.forsciint.2014.03.028","article-title":"Aminorex associated with possible idiopathic pulmonary hypertension in a cocaine user","volume":"240","author":"Karch","year":"2014","journal-title":"Forensic Sci Int"},{"issue":"12","key":"10.1016\/j.clinbiochem.2025.110912_b0390","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1007\/s00216-013-6829-x","article-title":"Metabolism of levamisole and kinetics of levamisole and aminorex in urine by means of LC-QTOF-HRMS and LC-QqQ-MS","volume":"405","author":"Hess","year":"2013","journal-title":"Anal Bioanal Chem"},{"issue":"10","key":"10.1016\/j.clinbiochem.2025.110912_b0395","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/dta.1619","article-title":"Determination of levamisole, aminorex, and pemoline in plasma by means of liquid chromatography-mass spectrometry and application to a pharmacokinetic study of levamisole","volume":"6","author":"Hess","year":"2014","journal-title":"Drug Test Anal"},{"key":"10.1016\/j.clinbiochem.2025.110912_b0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2022.132293","article-title":"An ultrasensitive monoclonal antibody-based lateral flow immunoassay for the rapid detection of xylazine in milk","volume":"383","author":"Chen","year":"2022","journal-title":"Food Chem"},{"issue":"1","key":"10.1016\/j.clinbiochem.2025.110912_b0405","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12954-023-00924-5","article-title":"Enhancing drug checking services for supply monitoring: perspectives on implementation in syringe service programs in the USA","volume":"21","author":"Moon","year":"2024","journal-title":"Harm Reduct J"},{"key":"10.1016\/j.clinbiochem.2025.110912_b0410","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ajem.2023.07.025","article-title":"Harm reduction and emergency medical services: Opportunities for evidence-based programming","volume":"72","author":"Friedman","year":"2023","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.clinbiochem.2025.110912_b0415","article-title":"Understanding sensitivity and cross-reactivity of xylazine lateral flow immunoassay test strips for drug checking applications","author":"Sisco","year":"2023","journal-title":"Drug Test Anal"},{"key":"10.1016\/j.clinbiochem.2025.110912_b0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2023.104154","article-title":"Xylazine in the drug supply: Emerging threats and lessons learned in areas with high levels of adulteration","volume":"120","author":"Quijano","year":"2023","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.clinbiochem.2025.110912_b0425","unstructured":"Authors, S. Jones, and S. Bailey, CADTH Horizon Scans, in Xylazine Test Strips for Drug Checking: CADTH Horizon Scan. 2023, Canadian Agency for Drugs and Technologies in Health: Ottawa (ON)."},{"issue":"5","key":"10.1016\/j.clinbiochem.2025.110912_b0430","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/jat\/9.5.234","article-title":"Xylazine in Human Tissues and Fluids in a Case of Fatal Drug Abuse","volume":"9","author":"Poklis","year":"1985","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.clinbiochem.2025.110912_b0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102770","article-title":"Analytical findings in used syringes from a syringe exchange program","volume":"81","author":"Fiorentin","year":"2020","journal-title":"Int J Drug Policy"},{"issue":"9\u201310","key":"10.1016\/j.clinbiochem.2025.110912_b0440","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/dta.1475","article-title":"Case report of accidental poisoning with the tranquilizer xylazine and the anesthetic ketamine confirmed by qualitative and quantitative toxicological analysis using GC-MS and LC-MSn","volume":"5","author":"Meyer","year":"2013","journal-title":"Drug Test. Anal."},{"issue":"3","key":"10.1016\/j.clinbiochem.2025.110912_b0445","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/jat\/31.3.165","article-title":"Solid-phase extraction and gas chromatographic-mass spectrometric determination of the veterinary drug xylazine in human blood","volume":"31","author":"Barroso","year":"2007","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.clinbiochem.2025.110912_b0450","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.aca.2019.01.029","article-title":"Rapid untargeted screening for drug residues in animal tissues with liquid microjunction surface sampling probe mass spectrometry","volume":"1063","author":"Burns","year":"2019","journal-title":"Anal. Chim. Acta"},{"issue":"2","key":"10.1016\/j.clinbiochem.2025.110912_b0455","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0378-4347(00)81066-X","article-title":"Determination of xylazine in plasma using high-performance liquid chromatography","volume":"222","author":"Alvinerie","year":"1981","journal-title":"J Chromatogr"},{"issue":"2","key":"10.1016\/j.clinbiochem.2025.110912_b0460","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/chromsci\/bmr036","article-title":"Simultaneous HPLC-UV determination of ketamine, xylazine, and midazolam in canine plasma","volume":"50","author":"Li","year":"2012","journal-title":"J Chromatogr Sci"},{"issue":"1\u20132","key":"10.1016\/j.clinbiochem.2025.110912_b0465","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S1570-0232(03)00215-0","article-title":"Simultaneous determination of ketamine and xylazine in canine plasma by liquid chromatography with ultraviolet absorbance detection","volume":"791","author":"Niedorf","year":"2003","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"1","key":"10.1016\/j.clinbiochem.2025.110912_b0470","first-page":"149","article-title":"Determination of residues of carazolol and a number of tranquilizers in swine kidney by high-performance liquid chromatography with ultraviolet and fluorescence detection","volume":"464","author":"Keukens","year":"1989","journal-title":"J Chromatogr"},{"issue":"2","key":"10.1016\/j.clinbiochem.2025.110912_b0475","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0378-4347(00)82875-3","article-title":"Rapid extraction and determination of xylazine in greyhound urine using high-performance liquid chromatography","volume":"491","author":"Moore","year":"1989","journal-title":"J Chromatogr"},{"issue":"1","key":"10.1016\/j.clinbiochem.2025.110912_b0480","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0378-4347(00)81945-3","article-title":"Determination of xylazine in blood components using high-performance liquid chromatography","volume":"426","author":"Akbari","year":"1988","journal-title":"J Chromatogr"},{"issue":"12","key":"10.1016\/j.clinbiochem.2025.110912_b0485","doi-asserted-by":"crossref","first-page":"5702","DOI":"10.1021\/jf0102362","article-title":"Determination of levamisole in animal tissues using liquid chromatography with ultraviolet detection","volume":"49","author":"Dreassi","year":"2001","journal-title":"J Agric Food Chem"},{"issue":"1\u20132","key":"10.1016\/j.clinbiochem.2025.110912_b0490","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0021-9673(92)85696-Q","article-title":"Determination of tranquilisers and carazolol residues in animal tissue using high-performance liquid chromatography with electrochemical detection","volume":"624","author":"Rose","year":"1992","journal-title":"J Chromatogr"},{"key":"10.1016\/j.clinbiochem.2025.110912_b0495","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/5746305","article-title":"Development of RP-HPLC Method for the Simultaneous Quantitation of Levamisole and Albendazole: Application to Assay Validation","volume":"2018","author":"Sowjanya","year":"2018","journal-title":"Int J Anal Chem"},{"issue":"2","key":"10.1016\/j.clinbiochem.2025.110912_b0500","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF03226369","article-title":"Quantitation of levamisole in plasma using high performance liquid chromatography","volume":"20","author":"Vandamme","year":"1995","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"2","key":"10.1016\/j.clinbiochem.2025.110912_b0505","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jchromb.2003.08.025","article-title":"Liquid chromatographic method with ultraviolet absorbance detection for measurement of levamisole in chicken tissues, eggs and plasma","volume":"796","author":"El-Kholy","year":"2003","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"1","key":"10.1016\/j.clinbiochem.2025.110912_b0510","first-page":"86","article-title":"Assessment of stability of ketamine-xylazine preparations with or without acepromazine using high performance liquid chromatography-mass spectrometry","volume":"80","author":"Dodelet-Devillers","year":"2016","journal-title":"Can J Vet Res"},{"issue":"6","key":"10.1016\/j.clinbiochem.2025.110912_b0515","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/jat\/29.6.544","article-title":"Determination of acepromazine, ketamine, medetomidine, and xylazine in serum: multi-residue screening by liquid chromatography-mass spectrometry","volume":"29","author":"Miksa","year":"2005","journal-title":"J Anal Toxicol"},{"issue":"5","key":"10.1016\/j.clinbiochem.2025.110912_b0520","article-title":"LC-MS\/MS Application in Pharmacotoxicological Field: Current State and New Applications","volume":"28","author":"D'Ovidio","year":"2023","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.clinbiochem.2025.110912_b0525","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2298\/VSP141105022B","article-title":"Fatal cocaine intoxication in a body packer","volume":"73","author":"Brajkovi\u0107","year":"2016","journal-title":"Vojnosanit Pregl"},{"issue":"46","key":"10.1016\/j.clinbiochem.2025.110912_b0530","doi-asserted-by":"crossref","first-page":"8165","DOI":"10.1016\/j.chroma.2009.07.036","article-title":"Determination of benzimidazoles and levamisole residues in milk by liquid chromatography-mass spectrometry: screening method development and validation","volume":"1216","author":"Jedziniak","year":"2009","journal-title":"J Chromatogr A"},{"issue":"12","key":"10.1016\/j.clinbiochem.2025.110912_b0535","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.3390\/molecules23123215","article-title":"Determination of Tranquilizers in Swine Urine by Ultra-High-Performance Liquid Chromatography-Tandem Mass Spectrometry","volume":"23","author":"Wang","year":"2018","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.clinbiochem.2025.110912_b0540","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s11419-019-00493-y","article-title":"Pharmacokinetic study of xylazine in a zebrafish water tank, a human-like surrogate, by liquid chromatography Q-Orbitrap mass spectrometry","volume":"38","author":"Matos","year":"2020","journal-title":"Forensic Toxicol."},{"issue":"6","key":"10.1016\/j.clinbiochem.2025.110912_b0545","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/jat\/bkv040","article-title":"Simultaneous determination of xylazine and 2,6-xylidine in blood and urine by auto solid-phase extraction and ultra high performance liquid chromatography coupled with quadrupole-time of flight mass spectrometry","volume":"39","author":"Gao","year":"2015","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.clinbiochem.2025.110912_b0550","first-page":"1","article-title":"Phospholipid adsorption polymeric materials for detection of xylazine and metabolite in blood and urine","volume":"2016","author":"Gao","year":"2016","journal-title":"International Journal of Polymer Science"},{"issue":"3","key":"10.1016\/j.clinbiochem.2025.110912_b0555","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/anatox\/35.3.176","article-title":"Detection of levamisole exposure in cocaine users by liquid chromatography-tandem mass spectrometry","volume":"35","author":"Lynch","year":"2011","journal-title":"J Anal Toxicol"},{"issue":"4","key":"10.1016\/j.clinbiochem.2025.110912_b0560","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1111\/1556-4029.13684","article-title":"Use of Xylazine in Drug-Facilitated Crimes","volume":"63","author":"Krongvorakul","year":"2018","journal-title":"J Forensic Sci"},{"issue":"1","key":"10.1016\/j.clinbiochem.2025.110912_b0565","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.aca.2009.02.033","article-title":"Aminorex and rexamino as metabolites of levamisole in the horse","volume":"638","author":"Ho","year":"2009","journal-title":"Anal Chim Acta"},{"key":"10.1016\/j.clinbiochem.2025.110912_b0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2020.139444","article-title":"Micro QuEChERS-based method for the simultaneous biomonitoring in whole blood of 360 toxicologically relevant pollutants for wildlife","volume":"736","author":"Rial-Berriel","year":"2020","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.clinbiochem.2025.110912_b0575","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.forsciint.2018.12.016","article-title":"Determination of cutting agents in seized cocaine samples using GC-MS","volume":"295","author":"Fiorentin","year":"2019","journal-title":"GC-TMS and LC-MS\/MS. Forensic Sci Int"},{"key":"10.1016\/j.clinbiochem.2025.110912_b0580","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jchromb.2015.06.005","article-title":"Quantitation of the anaesthetic xylazine in ovine plasma by LC-MS\/MS","volume":"997","author":"Doran","year":"2015","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"5","key":"10.1016\/j.clinbiochem.2025.110912_b0585","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/jat\/bks024","article-title":"Simultaneous determination of xylazine, free morphine, codeine, 6-acetylmorphine, cocaine and benzoylecgonine in postmortem blood by UPLC-MS-MS","volume":"36","author":"Ruiz-Col\u00f3n","year":"2012","journal-title":"J Anal Toxicol"},{"issue":"11","key":"10.1016\/j.clinbiochem.2025.110912_b0590","doi-asserted-by":"crossref","DOI":"10.3390\/foods10112841","article-title":"Determination of levamisole and mebendazole and its two metabolite residues in three poultry species by HPLC-MS\/MS","volume":"10","author":"Gao","year":"2021","journal-title":"Foods"},{"issue":"6","key":"10.1016\/j.clinbiochem.2025.110912_b0595","doi-asserted-by":"crossref","first-page":"T955","DOI":"10.1111\/1750-3841.12144","article-title":"Determination of xylazine and 2,6-xylidine in animal tissues by liquid chromatography\u2014tandem mass spectrometry","volume":"78","author":"Zheng","year":"2013","journal-title":"J. Food Sci."},{"issue":"5\u20136","key":"10.1016\/j.clinbiochem.2025.110912_b0600","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jchromb.2010.11.015","article-title":"A sensitive LC-MS\/MS method for determination of levamisole in human plasma: application to pharmacokinetic study","volume":"879","author":"Tong","year":"2011","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"2","key":"10.1016\/j.clinbiochem.2025.110912_b0605","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/anatox\/35.2.124","article-title":"Liquid chromatography-tandem mass spectrometry detection of the quaternary ammonium compound mebezonium as an active ingredient in t61","volume":"35","author":"Kirschbaum","year":"2011","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.clinbiochem.2025.110912_b0610","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.cca.2021.07.010","article-title":"High prevalence of xylazine among fentanyl screen-positive urines from hospitalized patients, Philadelphia, 2021","volume":"521","author":"Korn","year":"2021","journal-title":"Clin Chim Acta"},{"issue":"1","key":"10.1016\/j.clinbiochem.2025.110912_b0615","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1373\/clinchem.2015.241315","article-title":"Comparison of information-dependent acquisition on a tandem quadrupole TOF vs a triple quadrupole linear ion trap mass spectrometer for broad-spectrum drug screening","volume":"62","author":"Thoren","year":"2016","journal-title":"Clin Chem"},{"issue":"8","key":"10.1016\/j.clinbiochem.2025.110912_b0620","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3109\/15563650.2012.713108","article-title":"Role of liquid chromatography-high-resolution mass spectrometry (LC-HR\/MS) in clinical toxicology","volume":"50","author":"Wu","year":"2012","journal-title":"Clin Toxicol (phila)"},{"issue":"13","key":"10.1016\/j.clinbiochem.2025.110912_b0625","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal Chem"},{"issue":"3","key":"10.1016\/j.clinbiochem.2025.110912_b0630","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/(SICI)1096-9888(200003)35:3<423::AID-JMS953>3.0.CO;2-7","article-title":"Atmospheric pressure ionization time-of-flight mass spectrometry coupled with fast liquid chromatography for quantitation and accurate mass measurement of five pharmaceutical drugs in human plasma","volume":"35","author":"Zhang","year":"2000","journal-title":"J Mass Spectrom"},{"key":"10.1016\/j.clinbiochem.2025.110912_b0635","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jmsacl.2022.07.005","article-title":"Development and application of a High-Resolution mass spectrometry method for the detection of fentanyl analogs in urine and serum","volume":"26","author":"Zhang","year":"2022","journal-title":"J Mass Spectrom Adv Clin Lab"},{"issue":"21","key":"10.1016\/j.clinbiochem.2025.110912_b0640","doi-asserted-by":"crossref","first-page":"5710","DOI":"10.1021\/ac030162o","article-title":"Toxicological screening with formula-based metabolite identification by liquid chromatography\/time-of-flight mass spectrometry","volume":"75","author":"Pelander","year":"2003","journal-title":"Anal Chem"},{"issue":"1","key":"10.1016\/j.clinbiochem.2025.110912_b0645","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/jat\/29.1.34","article-title":"Application of accurate mass measurement to urine drug screening","volume":"29","author":"Ojanper\u00e4","year":"2005","journal-title":"J Anal Toxicol"},{"issue":"10","key":"10.1016\/j.clinbiochem.2025.110912_b0650","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0165-9936(03)01013-6","article-title":"Liquid chromatography\/time-of-flight\/mass spectrometry (LC\/TOF\/MS) for the analysis of emerging contaminants","volume":"22","author":"Ferrer","year":"2003","journal-title":"TrAC Trends Anal. Chem."},{"issue":"8","key":"10.1016\/j.clinbiochem.2025.110912_b0655","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1021\/ac800071n","article-title":"Implementation and performance evaluation of a database of chemical formulas for the screening of pharmaco\/toxicologically relevant compounds in biological samples using electrospray ionization-time-of-flight mass spectrometry","volume":"80","author":"Polettini","year":"2008","journal-title":"Anal Chem"},{"key":"10.1016\/j.clinbiochem.2025.110912_b0660","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.113958","article-title":"A portable electrochemical sensor for detection of the veterinary drug xylazine in beverage samples","volume":"198","author":"Saisahas","year":"2021","journal-title":"J Pharm Biomed Anal"},{"issue":"16","key":"10.1016\/j.clinbiochem.2025.110912_b0665","doi-asserted-by":"crossref","first-page":"13913","DOI":"10.1021\/acsomega.2c00295","article-title":"Nanocoral-like polyaniline-modified graphene-based electrochemical paper-based analytical device for a portable electrochemical sensor for xylazine detection","volume":"7","author":"Saisahas","year":"2022","journal-title":"ACS Omega"},{"issue":"12","key":"10.1016\/j.clinbiochem.2025.110912_b0670","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00604-022-05566-1","article-title":"Laser-scribed graphene on polyetherimide substrate: an electrochemical sensor platform for forensic determination of xylazine in urine and beverage samples","volume":"189","author":"de Lima","year":"2022","journal-title":"Mikrochim Acta"},{"key":"10.1016\/j.clinbiochem.2025.110912_b0675","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2023.137105","article-title":"Monitoring levamisole in food and the environment with high selectivity using an electrochemical chiral sensor comprising an MOF and molecularly imprinted polymer","volume":"430","author":"Li","year":"2024","journal-title":"Food Chem"},{"issue":"8","key":"10.1016\/j.clinbiochem.2025.110912_b0680","doi-asserted-by":"crossref","first-page":"5290","DOI":"10.1021\/acs.analchem.8b00204","article-title":"Levamisole: a common adulterant in cocaine street samples hindering electrochemical detection of cocaine","volume":"90","author":"de Jong","year":"2018","journal-title":"Anal Chem"},{"issue":"2","key":"10.1016\/j.clinbiochem.2025.110912_b0685","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/bio.2527","article-title":"A sensitive method for the determination of levamisole in serum by electrochemiluminescence","volume":"29","author":"Xiao","year":"2014","journal-title":"Luminescence"},{"key":"10.1016\/j.clinbiochem.2025.110912_b0690","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2023.111028","article-title":"Costing analysis of a point-of-care drug checking program in Rhode Island","volume":"253","author":"Cepeda","year":"2023","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.clinbiochem.2025.110912_b0695","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102661","article-title":"An assessment of the limits of detection, sensitivity and specificity of three devices for public health-based drug checking of fentanyl in street-acquired samples","volume":"77","author":"Green","year":"2020","journal-title":"Int J Drug Policy"},{"issue":"1","key":"10.1016\/j.clinbiochem.2025.110912_b0700","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12954-023-00764-3","article-title":"Point-of-care community drug checking technologies: an insider look at the scientific principles and practical considerations","volume":"20","author":"Gozdzialski","year":"2023","journal-title":"Harm Reduct J"},{"key":"10.1016\/j.clinbiochem.2025.110912_b0705","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108006","article-title":"Detecting fentanyl using point-of-care drug checking technologies: A validation study","volume":"212","author":"Ti","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.clinbiochem.2025.110912_b0710","unstructured":"Liebermann test. Oxford University Press: Oxford Reference."},{"key":"10.1016\/j.clinbiochem.2025.110912_b0715","unstructured":"Cocaine Testing Kit. 2023 [cited 2024 February 20th]; Available from: https:\/\/dancesafe.org\/product\/cocaine-testing-kit\/."},{"key":"10.1016\/j.clinbiochem.2025.110912_b0720","series-title":"Marquis test","author":"Daintith","year":"2008"},{"key":"10.1016\/j.clinbiochem.2025.110912_b0725","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0021-9673(00)82366-3","article-title":"Analysis of xylazine in biological material by gas chromatography using packed and capillary columns","volume":"216","author":"Rogstad","year":"1981","journal-title":"J. Chromatogr. A"},{"issue":"1","key":"10.1016\/j.clinbiochem.2025.110912_b0730","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0378-4347(00)80134-6","article-title":"Determination of levamisole in plasma and animal tissues by gas chromatography with thermionic specific detection","volume":"224","author":"Woestenborghs","year":"1981","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"issue":"1","key":"10.1016\/j.clinbiochem.2025.110912_b0735","first-page":"205","volume":"51","author":"Shea","year":"2013","journal-title":"Bioanalytical Methods for Quantitation of Levamisole, a Widespread Cocaine Adulterant"},{"issue":"1","key":"10.1016\/j.clinbiochem.2025.110912_b0740","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0379-0738(03)00083-5","article-title":"A reported case involving impaired driving following self-administration of xylazine","volume":"134","author":"Stillwell","year":"2003","journal-title":"Forensic Sci. Int."},{"issue":"1","key":"10.1016\/j.clinbiochem.2025.110912_b0745","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/1556-4029.13270","article-title":"Attempted Drug-facilitated Sexual Assault\u2014Xylazine Intoxication in a Child","volume":"62","author":"Andresen-Streichert","year":"2017","journal-title":"J. Forensic Sci."},{"issue":"3","key":"10.1016\/j.clinbiochem.2025.110912_b0750","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s002800050036","article-title":"Pharmacokinetics of levamisole in cancer patients treated with 5-fluorouracil","volume":"45","author":"Gwilt","year":"2000","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"1","key":"10.1016\/j.clinbiochem.2025.110912_b0755","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0378-4347(99)00334-5","article-title":"Gas chromatographic\u2013mass spectrometric analysis of veterinary tranquillizers in urine: evaluation of method performance","volume":"734","author":"Olmos-Carmona","year":"1999","journal-title":"J Chromatogr B Biomed Sci Appl."},{"issue":"5","key":"10.1016\/j.clinbiochem.2025.110912_b0760","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.jpba.2011.03.039","article-title":"Determination of aminorex in human urine samples by GC\u2013MS after use of levamisole","volume":"55","author":"Bertol","year":"2011","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"1","key":"10.1016\/j.clinbiochem.2025.110912_b0765","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jpba.2003.12.007","article-title":"Determination of xylazine and its metabolites by GC\u2013MS in equine urine for doping analysis","volume":"35","author":"Spyridaki","year":"2004","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.clinbiochem.2025.110912_b0770","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.forsciint.2014.11.028","article-title":"Analysis of cocaine and its adulterants in drugs for international trafficking seized by the Brazilian Federal Police","volume":"247","author":"Lapachinske","year":"2015","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.clinbiochem.2025.110912_b0775","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.forsciint.2018.12.016","article-title":"Determination of cutting agents in seized cocaine samples using GC\u2013MS, GC\u2013TMS and LC\u2013MS\/MS","volume":"295","author":"Fiorentin","year":"2019","journal-title":"Forensic Sci. Int."},{"issue":"8","key":"10.1016\/j.clinbiochem.2025.110912_b0780","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/anatox\/35.8.545","article-title":"Determination of levamisole in urine by gas chromatography-mass spectrometry","volume":"35","author":"Trehy","year":"2011","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.clinbiochem.2025.110912_b0785","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2020.110342","article-title":"Assessment of a portable quadrupole-based gas chromatography mass spectrometry for seized drug analysis","volume":"313","author":"Fiorentin","year":"2020","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.clinbiochem.2025.110912_b0790","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2020.110660","article-title":"Optimization of QuEChERS extraction for detection and quantification of 20 antidepressants in postmortem blood samples by LC-MS\/MS","volume":"319","author":"Camp\u00ealo","year":"2021","journal-title":"Forensic Sci Int"},{"issue":"4","key":"10.1016\/j.clinbiochem.2025.110912_b0795","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.clinbiochem.2005.01.014","article-title":"Multi-analyte procedures for screening for and quantification of drugs in blood, plasma, or serum by liquid chromatography-single stage or tandem mass spectrometry (LC-MS or LC-MS\/MS) relevant to clinical and forensic toxicology","volume":"38","author":"Maurer","year":"2005","journal-title":"Clin Biochem"},{"issue":"1\u20132","key":"10.1016\/j.clinbiochem.2025.110912_b0800","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0021-9673(01)01156-6","article-title":"Screening and identification of unknown contaminants in water with liquid chromatography and quadrupole-orthogonal acceleration-time-of-flight tandem mass spectrometry","volume":"929","author":"Bobeldijk","year":"2001","journal-title":"J Chromatogr A"},{"issue":"1","key":"10.1016\/j.clinbiochem.2025.110912_b0805","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0378-4347(01)00132-3","article-title":"Comparison between liquid chromatography-time of-flight mass spectrometry and selected reaction monitoring liquid chromatography-mass spectrometry for quantitative determination of idoxifene in human plasma","volume":"757","author":"Zhang","year":"2001","journal-title":"J Chromatogr B Biomed Sci Appl"},{"issue":"8","key":"10.1016\/j.clinbiochem.2025.110912_b0810","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1080\/15563650.2022.2063135","article-title":"Xylazine poisoning: a systematic review","volume":"60","author":"Ball","year":"2022","journal-title":"Clin Toxicol (phila)"},{"key":"10.1016\/j.clinbiochem.2025.110912_b0815","unstructured":"Hoffman, J. Tranq Dope: Animal Sedative Mixed With Fentanyl Brings Fresh Horror to U.S. Drug Zones. January 7th 2023 [cited 2024 February 13th]; Available from: https:\/\/www.nytimes.com\/2023\/01\/07\/health\/fentanyl-xylazine-drug.html."},{"key":"10.1016\/j.clinbiochem.2025.110912_b0820","first-page":"71","article-title":"The non-hematological side effects of levamisole in the treatment of rheumatoid arthritis\u2013a review","volume":"4","author":"Pinals","year":"1978","journal-title":"J Rheumatol Suppl"},{"issue":"4","key":"10.1016\/j.clinbiochem.2025.110912_b0825","first-page":"262","article-title":"Leukoencephalopathy after levamisole for the treatment of verrucae","volume":"20","author":"Cheng","year":"2011","journal-title":"Acta Neurol Taiwan"},{"issue":"1","key":"10.1016\/j.clinbiochem.2025.110912_b0830","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/MOH.0000000000000393","article-title":"Cocaine\/levamisole-associated autoimmune syndrome: a disease of neutrophil-mediated autoimmunity","volume":"25","author":"Cascio","year":"2018","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.clinbiochem.2025.110912_b0835","unstructured":"Cocaine Powder: Review of the evidence of prevalence and patterns of use, harms, and implications, T. Millar, Editor. 2015, Advisory Council on the Misuse of Drugs: GOV.UK."},{"key":"10.1016\/j.clinbiochem.2025.110912_b0840","unstructured":"Opioid Prevention Program \u2013 Data to Action: Xylazine Awareness in New York State, 2021. 2023, New York State Department of Health."},{"issue":"3","key":"10.1016\/j.clinbiochem.2025.110912_b0845","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/15563650.2022.2159427","article-title":"Opioid overdoses involving xylazine in emergency department patients: a multicenter study","volume":"61","author":"Love","year":"2023","journal-title":"Clin Toxicol (phila)"},{"issue":"8","key":"10.1016\/j.clinbiochem.2025.110912_b0850","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/jat\/bkac049","article-title":"Xylazine: pharmacology review and prevalence and drug combinations in forensic toxicology casework","volume":"46","author":"Kacinko","year":"2022","journal-title":"J Anal Toxicol"},{"issue":"5","key":"10.1016\/j.clinbiochem.2025.110912_b0855","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/dta.2047","article-title":"Pharmacokinetic and pharmacodynamics of xylazine administered to exercised thoroughbred horses","volume":"9","author":"Knych","year":"2017","journal-title":"Drug Test Anal"},{"key":"10.1016\/j.clinbiochem.2025.110912_b0860","article-title":"Evaluation of the ARK Diagnostics immunoassay for qualitative detection of xylazine in urine","author":"Patrick","year":"2024","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.clinbiochem.2025.110912_b0865","unstructured":"Group, T.F. The FDA's LDT Final Rule: Everything You Need to Know. 2024 May 30 2024]; Available from: https:\/\/www.thefdagroup.com\/blog\/fda-ldt-final-rule."},{"key":"10.1016\/j.clinbiochem.2025.110912_b0870","unstructured":"Administration, U.S.F.a.D. Final Rule: Medical Devices; Laboratory Developed Tests. 2024 May 30 2024]; Available from: https:\/\/www.fda.gov\/media\/178736\/download?attachment."},{"key":"10.1016\/j.clinbiochem.2025.110912_b0875","unstructured":"Assembly, P.G. Title 35 - 5902. Urine drug screening requirement. 2024 May 30 2024]; Available from: https:\/\/www.legis.state.pa.us\/cfdocs\/legis\/LI\/consCheck.cfm?txtType=HTM&ttl=35&div=0&chpt=59&sctn=2&subsctn=0."},{"issue":"3","key":"10.1016\/j.clinbiochem.2025.110912_b0880","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.jaad.2010.01.055","article-title":"Cocaine-associated retiform purpura and neutropenia: is levamisole the culprit?","volume":"63","author":"Waller","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clinbiochem.2025.110912_b0885","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.vascn.2015.09.001","article-title":"Measurement of ketamine and xylazine in rat brain by liquid\u2013liquid extraction and gas chromatography\u2013mass spectrometry","volume":"77","author":"Bonfanti","year":"2016","journal-title":"J. Pharmacol. Toxicol. Methods"},{"issue":"3","key":"10.1016\/j.clinbiochem.2025.110912_b0890","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.drugalcdep.2008.03.005","article-title":"GC\u2013MS confirmation of xylazine (Rompun), a veterinary sedative, in exchanged needles","volume":"96","author":"Rodr\u00edguez","year":"2008","journal-title":"Drug Alcohol Depend."},{"issue":"30","key":"10.1016\/j.clinbiochem.2025.110912_b0895","doi-asserted-by":"crossref","first-page":"9779","DOI":"10.1007\/s00216-013-7419-7","article-title":"Qualitative metabolism assessment and toxicological detection of xylazine, a veterinary tranquilizer and drug of abuse, in rat and human urine using GC\u2013MS, LC\u2013MSn, and LC\u2013HR-MSn","volume":"405","author":"Meyer","year":"2013","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.clinbiochem.2025.110912_b0900","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.forsciint.2018.02.001","article-title":"Analysis of cocaine adulterants in human brain in cases of drug-related death","volume":"285","author":"Knuth","year":"2018","journal-title":"Forensic Sci. Int."},{"issue":"6","key":"10.1016\/j.clinbiochem.2025.110912_b0905","doi-asserted-by":"crossref","DOI":"10.1097\/FTD.0000000000000076","article-title":"A direct immersion solid-phase microextraction gas chromatography\/mass spectrometry method for the simultaneous detection of levamisole and minor cocaine congeners in hair samples from chronic abusers","volume":"36","author":"Fucci","year":"2014","journal-title":"Ther. Drug Monit."},{"issue":"8","key":"10.1016\/j.clinbiochem.2025.110912_b0910","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/anatox\/35.8.545","article-title":"Determination of levamisole in urine by gas chromatography-mass spectrometry","volume":"35","author":"Trehy","year":"2011","journal-title":"J. Anal. Toxicol."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912025000414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912025000414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T18:51:39Z","timestamp":1763664699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912025000414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":182,"alternative-id":["S0009912025000414"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2025.110912","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rising illicit drug Adulterants: Xylazine and levamisole","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2025.110912","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The Canadian Society of Clinical Chemists.","name":"copyright","label":"Copyright"}],"article-number":"110912"}}